On March 20, Federal Trade Commission (FTC) Chairman Andrew N. Ferguson issued a memorandum directing the creation of an internal Healthcare Task Force. The directive underscores that healthcare remains a top enforcement and policy priority for the FTC, reflecting the Administration’s focus on a “more competitive, innovative, affordable, and higher quality healthcare system.”
Background
Chairman Ferguson’s memorandum highlights the outsized role of healthcare in the U.S. economy, approximately 18% of GDP, and the disconnect between that level of spending and many patients’ ongoing difficulty accessing affordable care. The memo links those challenges to consolidation and other forms of allegedly anticompetitive conduct across healthcare markets, as well as to regulations that may weaken incentives to lower costs or improve quality. The Chairman emphasizes the particular impact on vulnerable populations, including rural communities, seniors, and veterans.
The memo also stresses the FTC’s “dual mandate” to police both unfair or deceptive practices and unfair methods of competition. Against that backdrop, the Healthcare Task Force is designed to break down silos within the agency and between it and other agencies, leverage the FTC’s wide-ranging healthcare experience, and ensure that enforcement and advocacy efforts are aligned across the agency.
Key Points
- Knowledge Sharing and Market Intelligence
A central function of the Task Force will be to facilitate sharing of knowledge, resources, third‑party sources, market intelligence, case leads, and relationships with other agencies and stakeholders. This formal mechanism means that insights developed in one division (for example, in a consumer protection investigation) are more likely to inform other competition or policy initiatives. - Focus on Emerging Issues and Horizon‑Scanning
The Task Force will conduct ongoing “horizon‑scanning” exercises to identify emerging issues and new priority areas for enforcement and advocacy. This is likely to encompass digital health, telehealth, artificial intelligence (AI)‑enabled tools, health data platforms, and other technology‑driven business models in which the Office of Technology will play a meaningful role. - Expanded Inter‑Agency Collaboration
The memo explicitly calls for expanding participation to other government entities, including the Department of Health and Human Services and the Department of Justice, as well as other agency and law‑enforcement partners with relevant expertise. Companies may therefore see more coordinated activity across federal agencies on healthcare competition and consumer protection issues. - Continued Scrutiny of Consolidation and Market Power
By spotlighting recent merger challenges and references to “distorted” healthcare markets, the memo reinforces that consolidation will remain a core concern. Transactions involving hospitals, physician groups, payors, Pharmacy Benefit Managers (PBMs), device manufacturers, and other healthcare players — especially those affecting innovation or vulnerable patient populations — are likely to receive sustained scrutiny. - PBMs, Pricing, and Transparency as Key Priorities
The memorandum focuses on PBM practices, prescription drug pricing, and transparency. PBMs, plan sponsors, and manufacturers should expect continued attention to rebates, formulary design, steering, and related practices. - Aggressive Consumer Protection in Health‑Related Marketing
The memo recites a series of consumer protection actions in healthcare, including deceptive health plan marketing, misleading telehealth and weight‑loss programs, and products promoted with unsupported claims for serious conditions. Any entity marketing health‑related products or services should anticipate continued enforcement around claims substantiation, disclosures, endorsements, and steering.
Our Take
The FTC’s Healthcare Task Force does not have the authority to promulgate new statutes or regulations, but it does formalize and strengthen an integrated investigative and enforcement structure. By bringing together the Bureau of Competition, the Bureau of Consumer Protection, the Bureau of Economics, the Office of Policy Planning, and the Office of Technology, the agency hopes to move more quickly and effectively on healthcare matters that straddle antitrust, consumer protection, and technology. The task force appears an effort to foster an increasingly prevalent enforcement strategy that combines consumer protection and antitrust theories to increase the likelihood of successful challenges.